How should a 23-year-old male presenting with dysuria and urethral discharge be evaluated and treated?

Evaluation and Treatment of Dysuria with Urethral Discharge in a Young Male

Treat this 23-year-old male empirically with ceftriaxone plus doxycycline for presumed gonococcal and chlamydial urethritis, while simultaneously obtaining diagnostic testing to confirm the specific pathogen and guide partner notification.

Diagnostic Approach

Confirm Urethritis

The diagnosis of urethritis requires at least one of the following criteria 1:

• Visible mucopurulent or purulent urethral discharge
• Gram stain showing ≥2 white blood cells per oil immersion field
• First-void urinalysis with ≥10 white blood cells per high-power field
• Positive leukocyte esterase on first-void urine 2

Obtain Specific Pathogen Testing

Nucleic acid amplification tests (NAATs) are the preferred diagnostic method for both N. gonorrhoeae and C. trachomatis because they are more sensitive than traditional culture techniques 3. Testing should be performed on first-void urine or urethral swab specimens 1.

The two principal bacterial pathogens are 3:

• Neisseria gonorrhoeae (gonococcal urethritis)
• Chlamydia trachomatis (15-55% of nongonococcal urethritis cases)

Additional organisms to consider if initial testing is negative include Mycoplasma genitalium (10-30% of NGU), Ureaplasma urealyticum, Trichomonas vaginalis, and viral causes like HSV or adenovirus 4.

Empiric Treatment Strategy

First-Line Therapy

Initiate dual therapy immediately without waiting for laboratory results 1, 2:

• Ceftriaxone (for gonorrhea coverage) PLUS
• Doxycycline 100 mg twice daily for 7 days (for chlamydia and other NGU pathogens) 1, 4

This combination approach is critical because 3:

• Both gonorrhea and chlamydia are reportable conditions requiring public health notification
• Specific diagnosis enhances partner notification and treatment compliance
• Coinfection rates are substantial in this age group

Alternative Regimen

If doxycycline is contraindicated, azithromycin can be used, though azithromycin monotherapy as first-line treatment is discouraged because it selects for macrolide-resistant M. genitalium strains in the population 4.

Critical Management Steps

Partner Management

• Current sexual partner(s) must be tested and treated with the same regimen 4
• Expedited partner treatment (providing prescriptions for partners without examination) is advocated by the CDC and approved in many states 2
• Patient should abstain from sexual intercourse for 7 days after treatment initiation, until partners are adequately treated, and until symptoms fully resolve 1

Follow-Up Testing

• Do not perform repeat testing less than 3 weeks after treatment completion due to risk of false-positive results 1
• Patients treated for STIs should have repeat screening at 3 months 1
• If M. genitalium is identified, test of cure samples should be collected no earlier than 3 weeks after treatment start 4

Management of Persistent or Recurrent Symptoms

If symptoms persist after initial treatment, confirm urethritis recurrence with microscopy and consider 4:

If doxycycline was initial therapy:

• Azithromycin (extended 5-day course) PLUS metronidazole 400-500 mg twice daily for 5-7 days

If azithromycin was initial therapy:

• Doxycycline 100 mg twice daily for 7 days PLUS metronidazole, OR
• Moxifloxacin 400 mg once daily for 7-14 days (particularly for macrolide-resistant M. genitalium) 4

Testing for Atypical Organisms

If persistent urethritis or cervicitis occurs with negative initial testing, Mycoplasma genitalium testing is specifically recommended 5. This organism requires targeted therapy with moxifloxacin if macrolide resistance is present 4.

Common Pitfalls to Avoid

• Do not rely on virtual encounters without laboratory testing, as this increases recurrent symptoms and unnecessary antibiotic courses 5
• Do not treat with single-agent therapy when diagnostic tools are unavailable—always cover both gonorrhea and chlamydia 3
• Do not neglect partner treatment, as reinfection is a major cause of treatment failure 4
• Do not forget HIV testing, as urethritis is associated with increased HIV concentration in semen 2